La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Dopamine Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine < Dopamine Agents < Dopamine Agonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 70.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000023 (1999) E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E GrossInvolvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
000036 (1999) O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L MontastrucClinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000058 (1999) E. Broussolle [France] ; C. Dentresangle ; P. Landais ; L. Garcia-Larrea ; P. Pollak ; B. Croisile ; O. Hibert ; F. Bonnefoi ; G. Galy ; J C Froment ; D. ComarThe relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
000073 (1999) M. Gentil [France] ; C L Tournier ; P. Pollak ; A L BenabidEffect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000079 (1999) E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E GrossEffect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
000089 (2000) Andreas Hartmann [France] ; Stéphane Hunot [France] ; Patrick P. Michel [France] ; Marie-Paule Muriel [France] ; Sheela Vyas [Royaume-Uni] ; Baptiste A. Faucheux [France] ; Annick Mouatt-Prigent [France] ; Hélène Turmel [France] ; Anu Srinivasan [États-Unis] ; Merle Ruberg [France] ; Gerard I. Evan [Royaume-Uni] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
000091 (2000) T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E GrossEffects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
000094 (2000) A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. MoussaouiThe protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
000103 (2000) E C Hirsch [France]Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
000104 (2000) A L Benabid [France] ; A. Benazzouz ; P. Limousin ; A. Koudsie ; P. Krack ; B. Piallat ; P. PollakDyskinesias and the subthalamic nucleus.
000110 (2000) N. Fournet [France] ; O. Moreaud ; J L Roulin ; B. Naegele ; J. PellatWorking memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.
000179 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000223 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000244 (2002) Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000330 (2003) Erwan Bézard [France] ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre SokoloffAttenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
000348 (2003) H. Mollion [France] ; J. Ventre-Dominey ; P F Dominey ; E. BroussolleDissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
000352 (2003) Caroline Prunier [France] ; Erwan Bézard ; Jérôme Montharu ; Marina Mantzarides ; Jean-Claude Besnard ; Jean-Louis Baulieu ; Christian Gross ; Denis Guilloteau ; Sylvie ChalonPresymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.
000365 (2003) E C Hirsch [France] ; G. Höglinger ; E. Rousselet ; T. Breidert ; K. Parain ; J. Feger ; M. Ruberg ; A. Prigent ; C. Cohen-Salmon ; J M LaunayAnimal models of Parkinson's disease in rodents induced by toxins: an update.
000373 (1992) A. Benazzouz [France] ; C. Gross ; J. Dupont ; B. BioulacMPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies.
000406 (2003) N V Fedorova[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
000431 (2004) K. Ashkan [France] ; B. Wallace ; B A Bell ; A L BenabidDeep brain stimulation of the subthalamic nucleus in Parkinson's disease 1993-2003: where are we 10 years on?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Dopamine Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Dopamine Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agents
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024